研究限制

本研究之研究限制，可歸納出五點研究限制：

一、在研究過程上

1.本研究之對象主要由社區藥局藥師及各衛生所招募，來自社區 藥局與衛生所民眾可能有不同的就醫行為與特質，而有不一樣的民眾 特性。

2.本研究之樣本抽樣，屬於立意抽樣，在樣本代表性上，可能存 有偏誤的情況。

3.本研究之問卷量表項目係參考台中縣衛生局之藥師藥事諮詢 建議表，研究變項僅侷限探討藥師藥事諮詢建議表之藥事服務項目。

4.本研究因採用問卷調查方式，由社區藥局藥師將問卷交給民眾 填寫，因受訪的社區藥局藥師在場，民眾對社區藥局藥師整體藥師服 務滿意度會有高估的可能。

5.本研究之研究成果，僅能推估部份區域性社區藥局藥師的專業 藥事服務情況，因此，本研究之外推性將受到限制。

參考文獻

英文部分：

Abood, R.R. “Errors in pharmacy practice”. US Pharmacist. Vol. 21, pp.122-132, 1996.

American Society of Health-System Pharmacists, Government Affairs Division.

American Society of Health-System Pharmacists. Collaborative drug therapy management. Available: http://www.ashp.org/public/proad/index.html. Accessed 2002 Jan 14.

American Society of Hospital Pharmacists. “ASHP guidelines on a standardized method for pharmaceutical care”. American Journal of Hospital Pharmacy. Vol.

53, pp.1713-1716, 1996.

American Society of Hospital Pharmacists. “ASHP statement on pharmaceutical care”.

American Journal of Hospital Pharmacy. Vol. 50, pp.1720-1723, 1993.

Anderson, C., Blenkinsopp, A. and Armstrong, M. “Feedback from community pharmacy users on the contribution of community pharmacy to improving the public’s health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002”. Health Expect. Vol. 7, No. 3, pp.191-202, 2004.

Carmichael, J.M., O’Connell, M.B., Devine, B., Kelly, H.W., Ereshefsky, L. and Linn, W.D. “Collaborative Drug Therapy Management by Pharmacists”. American College of Clinical Pharmacy Pharmacotherapy. Vol. 17, pp.1050-1061, 1997.

Christensen, D.B. and Farris, K.B. “Pharmaceutical care in community pharmacies:

practice and research in the US”. Annals Pharmacotherapy. Vol. 40, No. 7-8, pp.1400-1406, 2006.

David, B.R., Paul, L.R. and Susan, P.R. “The conflict between ethics and business in community pharmacy: What about patient counseling?” Journal of Business Ethics. Vol. 28, No. 2, pp.179, 2000.

Dwain, D. and John, R. “Can ASHP’s 2015 goals be achieved?” Drug Topics. Vol.

151, No. 13, pp.48, 2007.

Earle, K.A., Taylor, P., Wyatt, S., Burnett, S. and Ray, J. “A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study”. Journal of Human Hypertension. Vol. 15, pp.529-533, 2001.

Elliott, R.A., Barber, N. and Horne, R. “Cost-effectiveness of adherence-enhancing

Vol. 39, No. 3, pp.508-515, 2005.

Falvo, D.R. Effective Patient Education: a guide to increased compliance, 2nd ed.

Gaithersburg, Maryland: Aspen Publishers, Inc. 1994.

Fornell, C. “A National Customer Satisfaction Barometer: The Swedish Experience”.

Journal of Marketing. Vol. 56, pp.6-21, 1992.

Hayashi, S., Hayase, T., Mochizuki, M., Hashiguchi, M. and Takeuchi, K.

“Classification of pharmaceutical services from the viewpoint of patient satisfaction/dissatisfaction”. Yakugaku Zasshi. Vol. 125, No. 1, pp.159-168, 2005.

Hepler, C.D. and Strand, L.M. “Opportunities and responsibilities in pharmaceutical care”. American Journal of Hospital Pharmacy. Vol. 47, No. 3, pp.533-543, 1990.

Johnson, J.A., Coons, S.J., Hays, R.D. and Pickard, A.S. “Health status and

satisfaction with pharmacy services”. American Journal of Managed Care. Vol.

5, No. 2, pp.163-170, 1999.

Julie, V., Diane, L., Marie-Claude, V., Marie-Therese, L., Jacques, G.., Eveline, H., Lucie, B., Sylvie, P. and Lyne, L. “How to help patients manage their

dyslipidemia: A primary care physician-pharmacist team intervention”.

Canadian Pharmacists Journal. Vol. 140, No. 5, pp.300, 2007.

Kresevic, D. and Holder, C. “Interdisciplinary care”. Clinics in Geriatric Medicine.

Vol. 14, pp.787-798, 1998.

Larson, L.N., Rovers, J.P. and Mackeigan, L.D. “Patient satisfaction with

pharmaceutical care: Update of a validated instrument”. Journal of the American Pharmaceutical Association. Vol. 42, No. 1, pp.44-50, 2002.

McDermott, J.H. and Christensen, D.B. “Provision of pharmaceutical care services in Notrh Carolina: a 1999 survey”. Journal of the American Pharmaceutical Association (Wash). Vol. 42, No. 1, pp.26-35, 2002.

Morrill, G.B. and Barreuther, C. “Screening Discharge Prescriptions”. American Journal of Hospital Pharmacy. Vol. 45, pp.1904-1905, 1988.

Moss, R.L., Garnett, W.R. and Steiner, K.C. “Physician attitudes toward pharmacists counseling patients on adverse drug reactions”. American Journal of Hospital Pharmacy. Vol. 37, No. 2, pp.24-37, 1980.

Onda, M., Fujii, Y., Yamamichi, Y. and Kono, K. “Structural features of pharmacy

Vol. 126, No. 10, pp.965-971, 2006.

Penna, R.P. “A Profession in transition or a transitory profession?” American Journal of Hospital Pharmacy. Vol. 44, pp.2053-2059, 1987.

Peter, M. “Physician-pharmacist teams help in control of blood-pressure”. The Lancet.

Vol. 352, No. 9139, pp.1528, 1998.

Rehder, T.L., McCoy, L.K., Blackwall, B., Whitehead, W. and Robinson, A.

“Improving medication compliance by counseling and special prescription container”. American Journal of Hospital Pharmacy. Vol. 37, pp.379-385, 1980.

Roberts, D.E., Spencer, M.G., Burfield, R. and Bowden, S. “An analysis of dispensing errors in UK hospitals”. International Journal of Pharmacy Practice. Vol. 10, No.

R6, 2002.

Rupp, M.T., McCallian, D.J. and Sheth, K.K. “Developing and marketing a community pharmacy-based asthma management program”. Journal of the American Pharmaceutical Association (Wash). Vol. NS37, No. 6, pp.694-699, 1997.

Seley, J.F. “10 strategies for successful patient teaching”. American Journal of Nursing. Vol. 4, pp. 63-65, 1994.

Singhal, P.K., Gupchup, G.V., Raisch, D.W., Schommer, J.C. and Holdsworth, Mt.

“Impact of pharmacists’ directive guidance behaviors on patient satisfaction”.

Journal of the American Pharmaceutical Association (Wash). Vol. 42, No. 3, pp.407-412, 2002.

Svarstad, B.L., Bultman, D.C. and Mount, J.K. “Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and

busyness”. Journal of the American Pharmaceutical Association. Vol. 44, No. 1, pp.22-29, 2004.

The role of the pharmacist in the health care system. Preparing the future pharmacist:

Curricular development. Report of a third WHO Consultative Group on the role of the pharmacist, Vancouver, Canada, 27-29 August 1997. Geneva: World Health Organization; 1997. WHO/PHARM/97/599. Available :

http://www.who.int/medicinedocs/

Van den Bemt, P.M., Egberts, T.C., de Jong-van den Berg, L.T. and Brouwers, J.R.

“Drug-related problems in hospitalised patients”. Drug Safety. Vol. 22, No. 4, pp.321-333, 2000.

blister-park, and its effect on drug compliance in a geriatric outpatient clinic”.

Journal of the American Geriatrics Society. Vol. 35, pp.21-26, 1987.

World Health Organization, Declaration of Alma-Ata. Geneva: World Health Organization; 1978.

中文部分：

第1_s 期，第 1-3 頁，民 96 年。

葉明功、林純青、Wallace, K. and Sergent, I.，“美國臨床藥學教育及醫院臨床藥 學現況”，台灣臨床藥學雜誌，第 11 卷，第 1 期，第 35-56 頁，民 92 年。

董千儀，持慢性病連續處方箋使用領藥民眾之認知與領藥行為及其接受醫院藥局

與社區藥局服務經驗之探討。台灣大學臨床藥學研究所碩士論文，民93 年。

詹麗珍，醫藥分業後社區藥局藥師執業現況。國立中山大學人力資源管理研究所 在職專班碩士論文，民91 年。

劉玉山、王佳惠、郭乃文，“醫院藥師提供用藥指導之態度與行為意向”，北市醫 學雜誌，第4 卷，第 2 期，第 73-86 頁，民 96 年。

蕭博文，“認識醫藥分業”，台灣衛生雙月刊，第 357 期，第 6-11 頁，民 86 年。

謝文紘、陳美霞，“醫藥分業政策推行對藥師專業的影響”，台灣衛誌，第 20 卷，

第5 期，第 395-411 頁，民 90 年。

簡修瑜，“健康照護新觀點”，藥師週刊電子報，第 1512 期，民 96 年。

醫策會網站之病人安全專區，http://www.tjcha.org.tw/，民 96 年。

譚延輝，“前導性探討藥師進行判斷性服務之價值”，台灣臨床藥學雜誌，第 11 卷，第1 期，第 1-18 頁，民 92 年。

譚延輝，“藥師的專業功能”，醫院雜誌，第 29 卷，第 4 期，第 44-51 頁，民 85 年。

譚延輝，藥學之專業執業，台北：九州圖書文物有限公司出版，民85 年。

譚延輝，藥學專業之發展，台北：九州圖書文物有限公司出版，民84 年。